AstraZeneca Plc made an official statement on Friday, saying that it rejected the increased bid of Pfizer Inc. Pfizer Inc. made an acquisition proposal, which amounted to 63.1 billion pounds (106.5 billion dollars) but was denied because in AstraZeneca's opinion Pfizer hadnt taken into account the promising perspectives of its drugs under development.